March 5, 2024 01:05 PM EST
Pharma
Marketing

Mar­ket­ingRx roundup: Pfiz­er jumps on lat­est Tik­Tok trend; No­vo re­cruits for Ca­griSe­ma tri­al across lan­guages

Beth Snyder Bulik

Senior Editor

Pfiz­er em­ploy­ees take on Tik­Tok trend: Pfiz­er sci­en­tists and so­cial me­dia man­agers are jump­ing on the cur­rent “We Are” Tik­Tok trend in which peo­ple give …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times